[1]
|
Homburg, R. and Crawford, G. (2014) The Role of AMH in Anovulation Associated with PCOS: A Hypothesis. Hu-man Reproduction, 29, 1117-1121. https://doi.org/10.1093/humrep/deu076
|
[2]
|
Sathyapalan, T., Al-Qaissi, A., Kilpatrick, E.S., et al. (2018) Anti-Mullerian Hormone Measurement for the Diagnosis of Polycystic Ovary Syndrome. Clinical Endocrinology, 88, 258-262. https://doi.org/10.1111/cen.13517
|
[3]
|
Sonigo, C., Beau, I., Grynberg, M. and Binart, N. (2019) AMH Prevents Primordial Ovarian Follicle Loss and Fertility Alteration in Cyclophospha-mide-Treated Mice. The FASEB Journal, 33, 1278-1287.
https://doi.org/10.1096/fj.201801089R
|
[4]
|
Yang, M.Y., Cushman, R.A. and Fortune, J.E. (2017) Anti-Mullerian Hormone Inhibits Activation and Growth of Bovine Ovarian Follicles in Vitro and Is Localized to Growing Follicles. Molecular Human Reproduction, 23, 282-291.
https://doi.org/10.1093/molehr/gax010
|
[5]
|
Ilha, G.F., Rovani, M.T., Gasperin, B.G., et al. (2016) Regulation of Anti-Mullerian Hormone and Its Receptor Expression around Follicle Deviation in Cattle. Reproduction in Domestic Animals, 51, 188-194.
https://doi.org/10.1111/rda.12662
|
[6]
|
Alipour, F., Rasekhjahromi, A., Maalhagh, M., et al. (2015) Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure. Disease Markers, 2015, Article ID: 585604.
https://doi.org/10.1155/2015/585604
|
[7]
|
Dewailly, D., Andersen, C.Y., Balen, A., et al. (2014) The Physiology and Clinical Utility of Anti-Mullerian Hormone in Women. Human Reproduction Update, 20, 370-385. https://doi.org/10.1093/humupd/dmt062
|
[8]
|
Dumont, A., Robin, G. and Dewailly, D. (2018) Anti-Mullerian Hormone in the Pathophysiology and Diagnosis of Polycystic Ovarian Syndrome. Current Opinion in Endocrinology, Diabetes and Obesity, 25, 377-384.
https://doi.org/10.1097/MED.0000000000000445
|
[9]
|
Pigny, P., Jonard, S., Robert, Y. and Dewailly, D. (2006) Serum Anti-Mullerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syn-drome. The Journal of Clinical Endocrinology & Metabolism, 91, 941-945. https://doi.org/10.1210/jc.2005-2076
|
[10]
|
Asanidze, E., Kristesashvili, J., Pkhaladze, L. and Khomasuridze, A. (2019) The Value of Anti-Mullerian Hormone in the Management of Polycystic Ovary Syndrome in Adolescents. Gyne-cological Endocrinology, 35, 974-977.
https://doi.org/10.1080/09513590.2019.1616689
|
[11]
|
Bhide, P., Dilgil, M., Gudi, A., et al. (2015) Each Small Antral Follicle in Ovaries of Women with Polycystic Ovary Syndrome Produces More Antimullerian Hormone than Its Counterpart in a Normal Ovary: An Observational Cross- Sectional Study. Fertility and Sterility, 103, 537-541. https://doi.org/10.1016/j.fertnstert.2014.10.033
|
[12]
|
Evliyaoglu, O., Imöhl, M., Weiskirchen, R. and van Helden, J. (2020) Age-Specific Reference Values Improve the Diagnostic Performance of AMH in Polycystic Ovary Syndrome. Clinical Chemistry and Laboratory Medicine, 58, 1291-1301. https://doi.org/10.1515/cclm-2019-1059
|
[13]
|
Shi, X., Peng, D., Liu, Y., et al. (2019) Advantages of Serum Anti-Mullerian Hormone as a Marker for Polycystic Ovarian Syndrome. Laboratory Medicine, 50, 236-242. https://doi.org/10.1093/labmed/lmy068
|
[14]
|
Sova, H., Unki-la-Kallio, L., Tiitinen, A., et al. (2019) Hormone Profiling, Including Anti-Mullerian Hormone (AMH), for the Diagnosis of Polycystic Ovary Syndrome (PCOS) and Characterization of PCOS Phenotypes. Gynecological Endocrinology, 35, 595-600. https://doi.org/10.1080/09513590.2018.1559807
|
[15]
|
Recabarren, S.E., Smith, R., Rios, R., et al. (2008) Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metab-olism, 93, 1820-1826. https://doi.org/10.1210/jc.2007-2256
|
[16]
|
Detti, L., Christiansen, M.E., Francillon, L., et al. (2019) Serum Anti-Mullerian Hormone (AMH) in Mothers with Polycystic Ovary Syndrome (PCOS) and Their Term Fetuses. Systems Biology in Reproductive Medicine, 65, 147-154.
https://doi.org/10.1080/19396368.2018.1537385
|
[17]
|
Valgeirsdottir, H., Vanky, E., Sundström-Poromaa, I., et al. (2019) Prenatal Exposures and Birth Indices, and Subsequent Risk of Polycystic Ovary Syndrome: A National Regis-try-Based Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology, 126, 244-251. https://doi.org/10.1111/1471-0528.15236
|
[18]
|
Tehrani, F.R., Yarandi, R.B., Solaymani-Dodaran, M., et al. (2020) Improving Prediction of Age at Menopause Using Multiple Anti-Mullerian Hormone Measurements: The Tehran Li-pid-Glucose Study. The Journal of Clinical Endocrinology & Metabolism, 105, 1589-1598. https://doi.org/10.1210/clinem/dgaa083
|
[19]
|
Tehrani, F.R., Solaymani-Dodaran, M. and Azizi, F. (2009) A Single Test of Antimullerian Hormone in Late Reproductive-Aged Women Is a Good Predictor of Menopause. Menopause, 16, 797-802.
https://doi.org/10.1097/GME.0b013e318193e95d
|
[20]
|
Kruszynska, A. and Slowinska-Srzednicka, J. (2017) An-ti-Mullerian Hormone (AMH) as a Good Predictor of Time of Menopause. Przeglad Menopauzalny, 16, 47-50. https://doi.org/10.5114/pm.2017.68591
|
[21]
|
Forslund, M., Landin-Wilhelmsen, K., Schmidt, J., et al. (2019) Higher Menopausal Age but No Differences in Parity in Women with Polycystic Ovary Syndrome Compared with Con-trols. Acta Obstetricia et Gynecologica Scandinavica, 98, 320-326. https://doi.org/10.1111/aogs.13489
|
[22]
|
Minooee, S., Tehrani, F.R., Rahmati, M., et al. (2018) Prediction of Age at Menopause in Women with Polycystic Ovary Syndrome. Climacteric, 21, 29-34. https://doi.org/10.1080/13697137.2017.1392501
|
[23]
|
Depmann, M., Eijkemans, M.J.C., Broer, S.L., et al. (2017) How Well Does AMH Relate to Timing of Menopause? Results of an Individual Patient Data Meta-Analysis. Maturitas, 100, 201.
https://doi.org/10.1016/j.maturitas.2017.03.325
|
[24]
|
Aydogan, B. and Mirkin, S. (2015) The Utility of Measuring Anti-Mullerian Hormone in Predicting Menopause. Climacteric, 18, 777-789. https://doi.org/10.3109/13697137.2015.1036853
|
[25]
|
Pilsgaard, F., Grynnerup, A.G.A., Løssl, K., et al. (2018) The Use of Anti-Mullerian Hormone for Controlled Ovarian Stimulation in Assisted Reproductive Technology, Fertility Assessment and -Counseling. Acta Obstetricia et Gynecologica Scandinavica, 97, 1105-1113. https://doi.org/10.1111/aogs.13334
|
[26]
|
Peuranpaa, P., Hautamäki, H., Halttunen-Nieminen, M., et al. (2020) Low Anti-Mullerian Hormone Level Is Not a Risk Factor for Early Pregnancy Loss in IVF/ICSI Treatment. Human Repro-duction, 35, 504-515.
https://doi.org/10.1093/humrep/deaa008
|
[27]
|
Borges, E., Braga, D., Setti, A., et al. (2017) The Predictive Value of Serum Concentrations of Anti-Mullerian Hormone for Oocyte Quality, Fertilization, and Implantation. JBRA Assisted Reproduction, 21, 176-182.
https://doi.org/10.5935/1518-0557.20170035
|
[28]
|
Siddiqui, Q.A., Anjum, S., Zahra, F., et al. (2019) Ovarian Re-serve Parameters and Response to Controlled Ovarian Stimulation in Infertile Patients. Pakistan Journal of Medical Sci-ences, 35, 958-962.
https://doi.org/10.12669/pjms.35.4.753
|
[29]
|
Pacchiarotti, A., Iaconianni, P., Caporali, S., et al. (2020) Severe En-dometriosis: Low Value of AMH Did Not Affect Oocyte Quality and Pregnancy Outcome in IVF Patients. European Review for Medical and Pharmacological Sciences, 24, 11488-11495.
|
[30]
|
Goswami, M. and Nikolaou, D. (2017) Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF? Journal of Human Reproductive Sciences, 10, 24-30.
|
[31]
|
Ligon, S., Lustik, M., Levy, G. and Pier, B. (2019) Low Antimullerian Hormone (AMH) Is Associated with Decreased Live Birth after in Vitro Fertilization When Follicle-Stimulating Hormone and AMH Are Discordant. Fertility and Sterility, 112, 73-81.E1. https://doi.org/10.1016/j.fertnstert.2019.03.022
|
[32]
|
Umarsingh, S., Adam, J.K. and Krishna, S. (2020) The Relationship between Anti-Müllerian Hormone (AMH) Levels and Pregnancy Outcomes in Pa-tients Undergoing Assisted Reproductive Techniques (ART). PeerJ, 8, e10390.
https://doi.org/10.7717/peerj.10390
|
[33]
|
Ciepiela, P., Dulęba, A.J., Kario, A., et al. (2019) Oocyte Matched Follic-ular Fluid Anti-Mullerian Hormone Is an Excellent Predictor of Live Birth after Fresh Single Embryo Transfer. Human Reproduction, 34, 2244-2253.
https://doi.org/10.1093/humrep/dez186
|
[34]
|
Dai, X., Wang, Y., Yang, H., et al. (2020) AMH Has No Role in Predicting Oocyte Quality in Women with Advanced Age Undergoing IVF/ICSI Cycles. Scientific Reports, 10, Article No. 19750.
https://doi.org/10.1038/s41598-020-76543-y
|